INTERNATIONAL PATENT: SCG CELL THERAPY PTE. LTD. FILES APPLICATION FOR "A MODIFIED DUAL-TARGETING T CELL RECEPTOR COMPLEX AND ITS PHARMACEUTICAL APPLICATION THEREOF"

GENEVA, April 27 -- SCG CELL THERAPY PTE. LTD. (138 Depot Road #04-02) filed a patent application (PCT/CN2025/128398) for "A MODIFIED DUAL-TARGETING T CELL RECEPTOR COMPLEX AND ITS PHARMACEUTICAL APPLICATION THEREOF" on Oct 17, 2025. With publication no. WO/2026/082164, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JIN, Tao (Building 21, Lane 100, Banxia RoadPudong New Area, Shanghai 201318), ZHANG, Ke (Building 21, Lane 100, Banxia RoadPudong New Area, Shanghai 201318), XIE, Pin (Building 21, Lane 100, Banxia RoadPudon...